Takuo Hayashi, Igor Odintsov, Roger S. Smith, Kota Ishizawa, Allan J. W. Liu, Lukas Delasos, . . . Romel Somwar. (2021). RET inhibition in novel patient-derived models of RET fusion- positive lung adenocarcinoma reveals a role for MYC upregulation. The Company of Biologists.
Chicago Style (17th ed.) CitationTakuo Hayashi, et al. RET Inhibition in Novel Patient-derived Models of RET Fusion- Positive Lung Adenocarcinoma Reveals a Role for MYC Upregulation. The Company of Biologists, 2021.
MLA (9th ed.) CitationTakuo Hayashi, et al. RET Inhibition in Novel Patient-derived Models of RET Fusion- Positive Lung Adenocarcinoma Reveals a Role for MYC Upregulation. The Company of Biologists, 2021.
Warning: These citations may not always be 100% accurate.